Furthermore, we found previously unreported protein alterations in PAH patients, such as alkaline phosphatase, tissue-nonspecific isozyme (ALPL), membrane metalloendopeptidase (MME), and versican (VCAN). This evidence concerns the gene MME and pulmonary arterial hypertension.